1. Home
  2. MBIO vs PPBT Comparison

MBIO vs PPBT Comparison

Compare MBIO & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • PPBT
  • Stock Information
  • Founded
  • MBIO 2015
  • PPBT 2010
  • Country
  • MBIO United States
  • PPBT Israel
  • Employees
  • MBIO N/A
  • PPBT N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBIO Health Care
  • PPBT Health Care
  • Exchange
  • MBIO Nasdaq
  • PPBT Nasdaq
  • Market Cap
  • MBIO 7.3M
  • PPBT 8.7M
  • IPO Year
  • MBIO N/A
  • PPBT N/A
  • Fundamental
  • Price
  • MBIO $2.80
  • PPBT $3.10
  • Analyst Decision
  • MBIO Strong Buy
  • PPBT Strong Buy
  • Analyst Count
  • MBIO 1
  • PPBT 2
  • Target Price
  • MBIO $100.00
  • PPBT $126.50
  • AVG Volume (30 Days)
  • MBIO 405.3K
  • PPBT 28.8K
  • Earning Date
  • MBIO 03-10-2025
  • PPBT 03-04-2025
  • Dividend Yield
  • MBIO N/A
  • PPBT N/A
  • EPS Growth
  • MBIO N/A
  • PPBT N/A
  • EPS
  • MBIO N/A
  • PPBT N/A
  • Revenue
  • MBIO N/A
  • PPBT N/A
  • Revenue This Year
  • MBIO N/A
  • PPBT N/A
  • Revenue Next Year
  • MBIO N/A
  • PPBT N/A
  • P/E Ratio
  • MBIO N/A
  • PPBT N/A
  • Revenue Growth
  • MBIO N/A
  • PPBT N/A
  • 52 Week Low
  • MBIO $2.40
  • PPBT $2.00
  • 52 Week High
  • MBIO $74.50
  • PPBT $20.60
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 29.74
  • PPBT 41.53
  • Support Level
  • MBIO $2.40
  • PPBT $2.90
  • Resistance Level
  • MBIO $3.04
  • PPBT $3.20
  • Average True Range (ATR)
  • MBIO 0.65
  • PPBT 0.21
  • MACD
  • MBIO 0.06
  • PPBT 0.00
  • Stochastic Oscillator
  • MBIO 9.30
  • PPBT 42.19

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Share on Social Networks: